|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT02099422 |
|
Date of registration:
|
26/03/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome
TOPIC |
|
Scientific title:
|
The Randomized TOPIC Study : Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome |
|
Date of first enrolment:
|
January 2013 |
|
Target sample size:
|
500 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT02099422 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case Control, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
thomas cuisset, MD-PHD |
|
Address:
|
|
|
Telephone:
|
33(0) 491385981 |
|
Email:
|
thomas.cuisset@ap-hm.fr |
|
Affiliation:
|
|
|
|
Name:
|
thomas cuisset, MD-PHD |
|
Address:
|
|
|
Telephone:
|
33(0)491385981 |
|
Email:
|
thomas.cuisset@ap-hm.fr |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- ACS and coronary stenting one month ago
Exclusion Criteria:
- age under 18 and pregnancy
Age minimum:
18 Years
Age maximum:
85 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Acute Coronary Syndrome
|
|
Antiplatelet Therapy
|
|
Coronary Stenting
|
|
Primary Outcome(s)
|
|
combined ischemic and hemorragic endpoint
[Time Frame: 12 months]
|
|
Secondary ID(s)
|
|
2013-A01168-37
|
|
APHM-011
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|